Egr-1 Negatively Regulates Human Tumor Cell Growth via the DNA-binding Domain

Cancer Research

Volumn 55, Issue 21, 1995, Pages 5054-5062

  Huang, Ruo Pan ^a   Fan, Yan ^a   Adamson, Eileen D ^a   Liu, Chaoting ^b   Mercola, Dan ^b,c  

^a BURNHAM INSTITUTE   (United States)

^b SIDNEY KIMMEL CANCER CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BINDING SITE; CELL TRANSFORMATION; CELL TYPE; DNA BINDING; FIBROSARCOMA; GENE EXPRESSION; GENETIC TRANSCRIPTION; GROWTH INHIBITION; GROWTH REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; TRANSCRIPTION REGULATION; TUMOR CELL CULTURE; TUMOR GROWTH;

EID: 0028862848     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Sukhatme, V. P. Early transcriptional events in cell growth: the Egr family. J. Am. Soc. Nephrol., 1: 859–866, 1990.
2. Ackerman, S. L., Minder, A. G., Williams, G. T., Bobonis, C., and Yeung, C.-Y. Functional significance of an overlapping consensus binding motif for Spl and Zif268 in the murine adenosine deaminase gene promoter. Proc. Natl. Acad. Sci. USA, 88: 7523–7527, 1991.
3. Gessler, M., Poustka, A., Cavenee, W., Neve, R. L., Orkin, S. H., and Brans, G. A. P. Homozygous deletion in Wilms' tumors of a zinc-finger gene identified by chromosome jumping. Nature (Lond.), 343: 774–778, 1990.
4. Bickmore, W. A., Oghene, K., Little, M. H., Seawright, A., van Heyningen, V., and Hastie, N. D. Modulation of DNA binding specificity by alternate splicing of the Wilms tumor wtl gene transcript. Science (Washington DC), 257: 235–237, 1992.
5. Wang, Z. Y., Qiu, Q. Q., Enger, K. T., and Deuel, T. F. A second transcriptionally active DNA-binding site for the Wilms tumor gene product. Proc. Natl. Acad. Sci. USA, 90: 8896–8900, 1993.
6. Christy, B., and Nathans, D. DNA-binding site of the growth factor-induciblc protein Zif268. Proc. Natl. Acad. Sci. USA, 86: 8737–8741, 1989.
7. Wang, Z.-Y., and Deuel, T. F. An S1 nuclease-sensitive homopurine/homopyrimidine domain in the PDGF A-chain promoter contains a novel binding site for the growth factor-inducible protein Egr-1. Biochem. Biophys. Res. Commun., 188: 433–439, 1992.
8. Huang, R. P., and Adamson, E. D. A biological role for Egr-1 in cell survival following ultra-violet irradiation. Oncogene, 10: 467–475, 1995.
9. Nguyen, H. Q., Hoffman-Libermann, B., and Liebermann, D. A. The Zinc-finger transcription factor Egr-1 is essential for and restricts differentiation along the macrophage lineage. Cell, 72: 197–209, 1993.
10. Darland, T., Samuels, M., Edwards, S. A., Sukhatme, V. P., and Adamson, E. D. Regulation of Egr-1 (Zfp-6) and c-fos expression in differentiating embryonal carcinoma cells. Oncogene, 6: 1367–1376, 1991.
11. Huang, R.-P., Darland, T., Okamura, D., Mercola, D., and Adamson, E. D. Suppression of v-sis-dependent transformation by the transcription factor, Egr-1. Oncogene, 9: 1367–1377, 1994.
12. Frisch, S. M., and Francis, H. Disruption of epithelial cell matrix interactions induces apoptosis. J. Cell. Biol., 124: 619–626, 1994.
13. Boshart, M., Weber, F., Jahn, G., Dorsch-Hasler, K., Fleckenstein, B., and Schaffner, W. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell, 41: 521–530, 1985.
14. Miller, A. D., and Rosman, G. J. Improved retroviral vectors for gene transfer and expression. Biotechniques, 7: 980–988, 1989.
15. Ragona, G., Edwards, S. A., Mercola, D. A., Adamson, E. D., and Calogero, A. The transcriptional factor Egr-1 is synthesized by Baculovirus-infected insect cells in an active, DNA-binding form. DNA Cell Biol., 10: 61–66, 1991.
16. Huang, R.-P., Ngo, L., Okamura, D., Tucker, M., and Adamson, E. D. V-sis induces Egr-1 expression by a pathway mediated by c-Ha-Ras and c-Raf-1. J. Cell. Biochem., 56: 469–479, 1994.
17. Levin, W. J., Baynor, R. B., Press, M. F., Sukhatme, V., and Slamon, D. J. Differential expression of immediate early transcription factors in human lung. J. Cell. Biochem., 16B: 240A, 1992.
18. Wilson, T. E., Day, M. L., Pexton, T., Padgett, K. A., Johnston, M., and Milbrandt, J. In vivo mutational analysis of the NGFI-A zinc fingers. J. Biol. Chem., 267: 3718–3724, 1992.
19. Goga, A., McLaughlin, J., Pendergast, A. M., Parmar, K., Müller, A., Rosenberg, N., and Witte, O. N. Oncogenic activation of c-abl by mutation within its last exon. Mol. Cell. Biol., 13: 4967–4975, 1993.
20. LeBeau, M. M., Albain, K. S., Larsen, R. A., Vardiman, J. W., Davis, E. M., Blough, R. R., and Golomg, H. M. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic anemia: further evidence for characteristic abnormalities of chromosomes numbers 5 and 7. J. Clin. Oncol., 4: 325–345, 1986.
21. Cho, K. R., and Vogelstein, B. Suppressor gene alterations in the colorectal adenoma-carcinoma sequence. J. Cell. Biochem. Suppl., 16G: 137–141, 1992.
22. Frisch, S. M. Ela induces the expression of epithelial characteristics. J. Cell Biol., 127: 1085–1096, 1994.
23. Liu, F., and Green, M. R. Promoter tergeting by adenovirus Ela through interaction with different cellular DNA-binding domains. Nature (Lond.), 368: 520–525, 1994.
24. Melillo, R. M., Heiin, K., Lowy, D. R., and Schiller, J. T. Positive and negative regulation of cell proliferation by E2F-1: influence of protein level and human papillomavirus oncoproteins. Mol. Cell. Biol., 14: 8241–8249, 1995.
25. Hofman, W., Royer, H.-D., Drechsler, M., Schneider, S., and Royer-Pokora, B. Characterization of the transcriptional regulatory region of the human WT1 gene. Oncogene, 8: 3123–3131, 1993.
26. Kim, S.-J., Park, K., Rudkin, B. B., Dey, B. R., Sporn, M. B., and Roberts, A. B. Nerve growth factor induces transcription of transforming growth factor-βl through a specific promoter element in PC12 cells. J. Biol. Chem., 269: 3739–3744, 1994.
27. Krämer, B., Meichle, A., Hensel, G., Charnay, P., and Krönke, M. Characterization of an Krox-24/Egr-l -responsive element in the human tumor necrosis factor promoter. Biochim. Biophys. Acta, 1219: 413–421, 1994.
28. Dey, B. R., Sukhatme, V. P., Roberts, A. B., Sporn, M. B., Rauscher, F. J., and Kim, S. J. Repression of the transforming growth factor-βl gene by the Wilms' tumor suppressor WT1 gene product. Mol. Endocrinol., 8: 595–602, 1994.
29. Roberts, A. B., and Sporn, M. B. Physiological actions and clinical application of transforming growth factor-β. Growth Factors, 8: 1–9, 1993.
30. Stouffer, G. A., and Owens, G. K. TGF-β promotes proliferation of cultured SMC via both PDGF-AA-dependent and PDGF-AA-independent mechanisms. J. Clin. Invest., 93: 2048–2055, 1994.
31. Battegay, E. J., Raines, E. W., Scifert, R. A., Bowen-Pope, D. F., and Ross, R. TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell, 63: 515–524, 1990.
32. Polyak, K., Lee, M. H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., and Massague, J. Cloning of p27Kipl, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78: 59–66, 1994.
33. Polyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M., and Koff, A. p27Kipl, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev., 8: 9–22, 1994.
34. Grainger, D. J., Witchell, C. M., Watson, J. V., Metcalfe, J. C., and Weissberg, P. L. Heparin decreases the rate of proliferation of rat vascular smooth muscle cells by releasing transforming growth factor β-like activity from serum. Cardiovasc. Res., 27: 2238–2247, 1993.
35. Grainger, D. J., Weissberg, P. L., and Metcalfe, J. C. Tamoxifen decreases the rate of proliferation of rat vascular smooth-muscle cells in culture by inducing production of transforming growth factor β. Biochem. J., 294: 109–112, 1993.